These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 37040844

  • 1. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis.
    Jin K, Shi Y, Zhang H, Zhangyuan G, Wang F, Li S, Chen C, Zhang J, Wang H, Zhang W, Sun B.
    J Hepatol; 2023 Aug; 79(2):403-416. PubMed ID: 37040844
    [Abstract] [Full Text] [Related]

  • 2. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.
    Zhang W, Zhangyuan G, Wang F, Jin K, Shen H, Zhang L, Yuan X, Wang J, Zhang H, Yu W, Huang R, Xu X, Yin Y, Zhong G, Lin A, Sun B.
    Immunity; 2021 Jun 08; 54(6):1168-1185.e8. PubMed ID: 34038747
    [Abstract] [Full Text] [Related]

  • 3. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q, Zhou H, Bu Q, Wei S, Li L, Zhou J, Zhou S, Su W, Liu M, Liu Z, Wang M, Lu L.
    J Hepatol; 2022 Aug 08; 77(2):312-325. PubMed ID: 35292349
    [Abstract] [Full Text] [Related]

  • 4. Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy.
    Zhou T, Chang L, Luo Y, Zhou Y, Zhang J.
    Redox Biol; 2019 Feb 08; 21():101120. PubMed ID: 30708325
    [Abstract] [Full Text] [Related]

  • 5. TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis.
    Wang X, Zeldin S, Shi H, Zhu C, Saito Y, Corey KE, Osganian SA, Remotti HE, Verna EC, Pajvani UB, Schwabe RF, Tabas I.
    J Hepatol; 2022 Apr 08; 76(4):910-920. PubMed ID: 34902531
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
    Zhang X, Fan L, Wu J, Xu H, Leung WY, Fu K, Wu J, Liu K, Man K, Yang X, Han J, Ren J, Yu J.
    J Hepatol; 2019 Jul 08; 71(1):163-174. PubMed ID: 30914267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Yang-Gan-Jiang-Mei formula alleviates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome through mitophagy.
    Wu Y, Kuang Y, Wu Y, Dai H, Bi R, Hu J, Sun L.
    Biotechnol Genet Eng Rev; 2024 Oct 08; 40(2):1314-1333. PubMed ID: 36960758
    [Abstract] [Full Text] [Related]

  • 10. Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis.
    Fu JT, Liu J, Wu WB, Chen YT, Lu GD, Cao Q, Meng HB, Tong J, Zhu JH, Wang XJ, Liu Y, Zhuang C, Sheng C, Shen FM, Liu X, Wang H, Yu Y, Zhang Y, Liang HY, Zhang JB, Li DJ, Li X, Wang ZB, Wang P.
    J Hepatol; 2024 Sep 08; 81(3):389-403. PubMed ID: 38670321
    [Abstract] [Full Text] [Related]

  • 11. A non-mitogenic FGF4 analog alleviates non-alcoholic steatohepatitis through an AMPK-dependent pathway.
    Wang L, Dong W, Gao H, Chen C, Liang S, Ye X, Liu Y, Hou Y, Fan L, Pan T, Wang Z, Chen Y, Luo Y, Song L.
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec 01; 1868(12):166560. PubMed ID: 36167161
    [Abstract] [Full Text] [Related]

  • 12. The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1.
    Yang Q, Chen X, Zhang Y, Hu S, Hu F, Huang Y, Ma T, Hu H, Tian H, Tian S, Ji YX, She ZG, Zhang P, Zhang XJ, Hu Y, Yang H, Yuan Y, Li H.
    Hepatology; 2021 Dec 01; 74(6):3018-3036. PubMed ID: 34272738
    [Abstract] [Full Text] [Related]

  • 13. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
    Morikawa R, Nakamoto N, Amiya T, Chu PS, Koda Y, Teratani T, Suzuki T, Kurebayashi Y, Ueno A, Taniki N, Miyamoto K, Yamaguchi A, Shiba S, Katayama T, Yoshida K, Takada Y, Ishihara R, Ebinuma H, Sakamoto M, Kanai T.
    J Hepatol; 2021 Mar 01; 74(3):511-521. PubMed ID: 33038434
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. RNF31 alleviates liver steatosis by promoting p53/BNIP3-related mitophagy in hepatocytes.
    Chen Y, Yang F, Shi Y, Sheng J, Wang Y, Zhang L, Zhou J, Jin Y, Yan Y.
    Free Radic Biol Med; 2024 Jul 01; 219():163-179. PubMed ID: 38615890
    [Abstract] [Full Text] [Related]

  • 17. MRG15 aggravates non-alcoholic steatohepatitis progression by regulating the mitochondrial proteolytic degradation of TUFM.
    Tian C, Min X, Zhao Y, Wang Y, Wu X, Liu S, Dou W, Zhou T, Liu Y, Luo R, Li Z, Lui KO, Li Y, Zhou B, Ding Q.
    J Hepatol; 2022 Dec 01; 77(6):1491-1503. PubMed ID: 35985547
    [Abstract] [Full Text] [Related]

  • 18. Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis.
    Liu W, Ye C, Cheng Q, Zhang X, Yao L, Li Q, Huang J, Liu Y, Zou Z, Wang H, Yan J, Zhu Y, Wang C, Ai D.
    Cell Mol Gastroenterol Hepatol; 2019 Dec 01; 7(1):211-231. PubMed ID: 30539788
    [Abstract] [Full Text] [Related]

  • 19. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.
    Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS.
    J Biol Chem; 2012 Nov 23; 287(48):40161-72. PubMed ID: 23066023
    [Abstract] [Full Text] [Related]

  • 20. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S, Rousseau D, Bonnafous S, Lebeaupin C, Luci C, Canivet CM, Schneck AS, Bertola A, Saint-Paul MC, Iannelli A, Gugenheim J, Anty R, Tran A, Bailly-Maitre B, Gual P.
    J Hepatol; 2017 Aug 23; 67(2):328-338. PubMed ID: 28323124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.